Given that SHP2 has been shown by several groups to regulate EGFR activity (Wu et al, 2000; Grossmann et al, 2010), it is not surprising that we also found SHP2 to be a significant marker of the classical subgroup of GBM. The gene discussed is PTPN11; the disease is glioblastoma.